October 27, 2025
Cerezen™ is the first and only device certified under the new EU framework. The US FDA is a bit slower to approve it.
October 27, 2025
Cerezen’s device has shown promise in some Alzheimer’s patients and is now approved for use in Europe.
October 27, 2025
EU approval means the innovative Cerezen device could soon be available in Europe, while U.S. patients must wait for the FDA’s greenlight.
May 7, 2025
Alois Alzheimer noted an association between blood flow and the disease that bears his name in 1906. So what happened?
